Evidence map›Paper›PMID 42458526›Full record

ArticleJournal of translational medicine2026

Exosome-mediated hepatocellular carcinoma progression by modulating macrophage metabolic reprogramming and macrophage M2 polarization via exosome-derived hsa_circ_0057320-miR-28-5p/E2F6 axis.

Lumin Wang, Chenyang Qiao, Zhiqiang Wang, Xiaofei Wang, Li Cao, Haitao Shi, Lu Li

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lumin Wang *Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, P. R. China. wanglumin1@xjtu.edu.cn.
Chenyang Qiao *Department of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, P. R. China.
Zhiqiang WangLiver Gall Bladder and Pancreatic Surgery Ward, Qinghai Red Cross Hospital, Xining, Qinghai, 810001, China.
Xiaofei WangKey Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, P. R. China.
Li CaoKey Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, 710061, P. R. China.
Haitao ShiDepartment of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, P. R. China. shihaitao7@163.com.
Lu LiDepartment of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, P. R. China. lhwzpd0a7@163.com.

Funding

Beijing Science and Technology Innovation Medical Development Foundation KC2023-JX-0186-FQ032
6 · The paper itself

Abstract

backgroundHepatocellular carcinoma is an aggressive malignancy with poor outcomes. Emerging studies highlight the importance of the tumor microenvironment in HCC progression, where exosomes serve as critical messengers linking tumor cells with surrounding stromal components. Although circRNAs are abundantly present in tumor-derived exosomes, their precise roles and mechanisms in HCC remain poorly defined.

methodsExosomes were characterized using transmission electron microscopy and flow cytometry. Differentially expressed circRNAs were identified by RNA sequencing. Macrophage polarization and metabolic reprogramming were evaluated by western blotting, immunofluorescence and metabolomics. The role of hsa_circ_0057320, miR-28-5p, and E2F6 in HCC progression was examined through transwell, tube formation, and spheroid-sprouting assays. Xenograft mouse models were constructed to verify the role of them in metastasis and angiogenesis, exosomes in progression of HCC. Interactions among hsa_circ_0057320, miR-28-5p, and E2F6 were explored using RIP and dual-luciferase reporter assays.

resultsIn this study, we found that exosomes derived from HOXD3-treated HCCs induced macrophage polarization toward the M2 phenotype via metabolic reprogramming. In addition, HOXD3-stimulated HCC cells secreted exosomes enriched in hsa_circ_0057320, which induce the alternatively activated (M2) macrophage phenotype and enhanced angiogenesis and metastatic capability in vivo and vitro. The role of hsa_circ_0057320 in the metastasis and invasion of HCC was reversed after the enhance of miR-28-5p. E2F6, a target of miR-28-5p, was markedly upregulated in HCC tissues and cells. Additionally, a positive relationship was established between hsa_circ_0057320 and E2F6, contrasting with a negative association with miR-28-5p.

conclusionsExosomes derived from HOXD3-induced HCC cells promotes M2 macrophage polarization via metabolic reprogramming. In addition, HOXD3-induced exosomal hsa_circ_0057320 promotes macrophage M2 polarization via the miR-28-5p/E2F6 axis, thereby accelerating HCC malignancy. These findings reveal the interactive communication mechanism between HCCs and TME, and highlight hsa_circ_0057320 as a potential exosomal indicator and therapeutic target for metastatic HCC.

Indexed as

Carcinoma, HepatocellularCell PolarityDisease ProgressionExosomesLiver NeoplasmsMacrophagesMetabolic ReprogrammingMicroRNAsRNA, CircularAnimalsBase SequenceCell Line, TumorGene Expression Regulation, NeoplasticHumansMacrophage ActivationMaleMicroRNAsRNA, CircularAngiogenesisExosomal circRNAHepatocellular carcinomahsa_circ_0057320Macrophage polarizationMetabolic reprogramming

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.